newsfilter
← Latest News
GlobeNewswire·

Climb Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates

CLYM116 Phase 1 data in healthy volunteers to be presented at R&D Spotlight Event on September 3, 2026 Anticipate CLYM116 Phase 2 trial in IgA nephropathy to initiate dosing in Q3 2026 Budoprutug clinical